Dr. Stefanie Urlinger

Scientific Advisor

Stefanie is a Molecular Biologist with an extensive experience in antibody technologies and development. She earned her PhD in the group of Robert Tampe at the Max-Planck-Institute for Biochemistry, Martinsried and conducted her postdoctoral studies with Wolfgang Hillen, University Erlangen-Nürnberg. During her 16 years at MorphoSys she was in charge of the development of antibody platform technologies as well as therapeutic antibody programs. Since October 2016 Stefanie is with iOmx Therapeutics where she serves as Senior Director Drug Development and Project Management, being responsible for the early antibody drug development.